Sinco Pharmaceutical Holdings (HKSE:06833) Dividend Payout Ratio: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06833 Sinco Pharmaceutical Holdings Ltd HKSE:06833
44 GF Score
Price HK$0.17
GF Value HK$0.19
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Sinco Pharmaceutical Holdings Dividend Payout Ratio?

Sinco Pharmaceutical Holdings HKSE:06833 -0.60% 44 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates HKSE:06833 with a GF Score™ of 44/100 and a GF Value™ of HK$0.19 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 63 Medical Distribution companies, Sinco Pharmaceutical Holdings ranks better than 88.89% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the months ended in Dec. 2025 was 0.00.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Dividend Payout Ratio or its related term are showing as below:

HKSE:06833' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.19   Max: 0.44
Current: 0.11


During the past 12 years, the highest Dividend Payout Ratio of Sinco Pharmaceutical Holdings was 0.44. The lowest was 0.11. And the median was 0.19.

HKSE:06833's Dividend Payout Ratio is ranked better than
88.89% of 63 companies
in the Medical Distribution industry
Industry Median: 0.43 vs HKSE:06833: 0.11

As of today (2026-08-28), the Dividend Yield % of Sinco Pharmaceutical Holdings is 1.02%.

During the past 12 years, the highest Trailing Annual Dividend Yield of Sinco Pharmaceutical Holdings was 5.78%. The lowest was 0.41%. And the median was 1.67%.

Sinco Pharmaceutical Holdings's Dividends per Share for the months ended in Dec. 2025 was HK$0.00.

During the past 12 months, Sinco Pharmaceutical Holdings's average Dividends Per Share Growth Rate was -50.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Sinco Pharmaceutical Holdings (HKSE:06833) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Sinco Pharmaceutical Holdings Dividend Payout Ratio Related Terms


Sinco Pharmaceutical Holdings Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Sinco Pharmaceutical Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinco Pharmaceutical Holdings Dividend Payout Ratio Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.44 0.17 0.11

Sinco Pharmaceutical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.31 0.00 0.17 0.00

HKSE:06833 vs MCK, COR, CAH: Dividend Payout Ratio Comparison

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings Dividend Payout Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Dividend Payout Ratio falls into.


HKSE:06833
44GF Score
Sinco Pharmaceutical Holdings Ltd HKSE:06833
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinco Pharmaceutical Holdings Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.002/ 0.019
=0.11

Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ 0.006
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Sinco Pharmaceutical Holdings (HKSE:06833) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sinco Pharmaceutical Holdings and its competitors. Over the past decade, Sinco Pharmaceutical Holdings' Dividend Payout Ratio has ranged from 0.11 to 0.44. According to the industry distribution chart, Sinco Pharmaceutical Holdings ranks #7 out of 63 companies in the Medical Distribution industry, placing it in the top 11.1%.
Is Sinco Pharmaceutical Holdings' Dividend Payout Ratio too high?
Sinco Pharmaceutical Holdings' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.44. Based on the distribution chart, Sinco Pharmaceutical Holdings ranks #7 out of 63 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sinco Pharmaceutical Holdings has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinco Pharmaceutical Holdings' Dividend Payout Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinco Pharmaceutical Holdings ranks #7 out of 63 companies for Dividend Payout Ratio. This places Sinco Pharmaceutical Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.43. Historically, Sinco Pharmaceutical Holdings' own Dividend Payout Ratio has ranged from 0.11 to 0.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 63 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sinco Pharmaceutical Holdings and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinco Pharmaceutical Holdings's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinco Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinco Pharmaceutical Holdings (HKSE:06833) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.19, compared to a current price of HK$0.17 — trading 12.6% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Sinco Pharmaceutical Holdings' overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Sinco Pharmaceutical Holdings (HKSE:06833), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinco Pharmaceutical Holdings (HKSE:06833) Overvalued in 2026?

Based on GuruFocus' analysis, Sinco Pharmaceutical Holdings stock appears to be undervalued. The current stock price of HK$0.17 is trading 12.6% below its estimated GF Value™ of HK$0.19. GuruFocus considers Sinco Pharmaceutical Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:06833:

  • Dividend Payout Ratio: 0.00
  • GF Value™: HK$0.19 vs. price of HK$0.17 (12.6% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the HKSE:06833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinco Pharmaceutical Holdings Business Description

Address No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
44GF Score

Get the complete analysis for HKSE:06833

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.17
Price
HK$0.19
GF Value